Integrated design of a chitosan-coated emulsomal hydrogel for transdermal delivery of terbutaline sulfate: from optimization to in vivo performance
RSC Pharmaceutics · 2026
DOI: 10.1039/d6pm00281a ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Rofida Albash und 5 weiteren Autor:innen. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
This study aimed to enhance the transdermal delivery of terbutaline sulfate (TBL) by using chitosan (CS)-coated bioadhesive emulsomes (EMLs) to overcome the poor oral bioavailability associated with extensive hepatic first-pass metabolism.
Zitieren
APA
Albash, R., Al-Sawahli, M., Fares, A. R., Elshafeey, A. H., Agiba, A. M., & El-Dahmy, R. M. (2026). Integrated design of a chitosan-coated emulsomal hydrogel for transdermal delivery of terbutaline sulfate: from optimization to in vivo performance. RSC Pharmaceutics. https://doi.org/10.1039/d6pm00281a
Vancouver
Albash R, Al-Sawahli M, Fares AR, Elshafeey AH, Agiba AM, El-Dahmy RM. Integrated design of a chitosan-coated emulsomal hydrogel for transdermal delivery of terbutaline sulfate: from optimization to in vivo performance. RSC Pharmaceutics. 2026. doi:10.1039/d6pm00281a
BibTeX
@article{Albash2026,
author = {Albash, Rofida and Al-Sawahli, Majid and Fares, Ahmed R. and Elshafeey, Ahmed Hassen and Agiba, Ahmed M. and El-Dahmy, Rania Moataz},
title = {Integrated design of a chitosan-coated emulsomal hydrogel for transdermal delivery of terbutaline sulfate: from optimization to in vivo performance},
journal = {RSC Pharmaceutics},
year = {2026},
doi = {10.1039/d6pm00281a}
}
EUVIMED